News

As per the deal, Roche will commence an all cash tender offer for all outstanding shares of common stock of Anadys. Anadys president and CEO Steve Worland said

Nyloxin is an OTC pain reliever which treats moderate to severe chronic pain. Currently, the product is available in the US as an oral spray for treating back

According to the company, the sales of these products would strengthen their product offering and is hopeful to be a solid contributor to both sales and profits in

The company is said to have increased the production to supply the US market and meet the clinical needs of health care professionals. Propofol, marketed under the brand

VeriStrat is a serum proteomic for patients with advanced NSCLC, which identifies patients likely to have good or poor outcomes after treatment with epidermal growth factor receptor inhibitors

eFuture had signed multiple contracts with Beijing Jingxinlong in 2010, covering end-to-end logistics management solutions. The pharmaceutical distributor is said to have selected eFuture for its logistics IT

The clinical holds placed on the trial were based on an initial review by FDA of the interim results of a long-term rat inhalation carcinogenicity study reported to

According to the deal, BeiGene will in-license intetumumab (CNTO-95) for clinical development and commercialization within Australia, China, Hong Kong, New Zealand, Korea, Singapore and Taiwan. Intetumumab is a

The combined company will have its presence established in more than 60 countries and generated nearly $20bn revenues on a pro-forma basis for the twelve months ended June